You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE


✉ Email this page to a colleague

« Back to Dashboard


CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634 NDA B. Braun Medical Inc. 0264-7751-00 12 CONTAINER in 1 CASE (0264-7751-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634 NDA B. Braun Medical Inc. 0264-7751-10 24 CONTAINER in 1 CASE (0264-7751-10) / 500 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634 NDA B. Braun Medical Inc. 0264-7751-00 12 CONTAINER in 1 CASE (0264-7751-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634 NDA B. Braun Medical Inc. 0264-7751-10 24 CONTAINER in 1 CASE (0264-7751-10) / 500 mL in 1 CONTAINER 1988-02-24
Fresenius Kabi Usa DEXTROSE 5% AND LACTATED RINGER'S calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 210332 ANDA Fresenius Kabi USA, LLC 65219-241-10 10 BAG in 1 CASE (65219-241-10) / 1000 mL in 1 BAG (65219-241-00) 2022-03-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Essential Intravenous Solutions: Calcium Chloride, Dextrose, Potassium Chloride, Sodium Chloride, and Sodium Lactate

Last updated: July 30, 2025

Introduction

The global pharmaceutical supply chain for intravenous (IV) solutions relies on a diverse network of raw material suppliers. These ingredients—calcium chloride, dextrose, potassium chloride, sodium chloride, and sodium lactate—are pivotal in compounding sterile solutions used across hospitals worldwide. Ensuring the quality, reliability, and compliance of these raw materials is critical for pharmaceutical manufacturers. This analysis explores the key suppliers for these substances, scrutinizing their market positioning, manufacturing capacity, regulatory compliance, and strategic significance.

Market Overview and Regulatory Landscape

Intravenous solutions demand pharmaceutical-grade raw materials that meet strict pharmacopoeial standards such as USP, EP, and JP. Suppliers operating at scale must adhere to Good Manufacturing Practices (GMP), ISO certifications, and environmental standards. As global demand surges—driven by aging populations and increased hospitalizations—the supplier landscape adapts to facilitate consistent supply and supply chain resilience.

Suppliers of Calcium Chloride

Global Leaders and Major Suppliers

  • Sidley Pharmaceuticals: A prominent manufacturer based in India, Sidley Pharmaceuticals offers high-quality calcium chloride dihydrate, complying with USP and EP standards. Their extensive distribution network caters to North America, Europe, and Asia-Pacific markets.

  • GFS Chemicals: A US-based supplier supplying pharmaceutical-grade calcium chloride with a focus on custom formulations and regulatory compliance.

  • Hubei Greenwell Pharmaceutical: In China, Greenwell is recognized for large-scale production aligned with international standards, serving growing Asian markets.

  • Yungfeng Pharmaceutical: Also in China, Yungfeng produces calcium chloride solutions for sterile applications with GMP-certified facilities.

Strategic Considerations

Suppliers that demonstrate GMP compliance, robust quality assurance frameworks, and capacity for large-volume production are critical. Companies like Sidley and GFS Chemicals have established reputations, offering reliable supply chains and swift response capabilities, pivotal during periods of supply disruption.


Suppliers of Dextrose (D-glucose)

Leading Manufacturers

  • Cargill, Inc.: A dominant global supplier with extensive capacity for dextrose monohydrate and anhydrous forms. Cargill's products meet USP and FDA standards, with integrated quality control systems.

  • Roquette Frères: French-based multinational specializing in pharmaceutical-grade dextrose, with a focus on high purity and low endotoxin levels suitable for IV solutions.

  • Ingredion Incorporated: US-based supplier providing dextrose derived from corn, with flexible supply chains tailored for pharmaceutical applications.

  • TPC Group (Akin, TX): Known for refined dextrose products with rigorous quality assurance, widely used in hospital IV solutions.

Key Attributes

Leading suppliers maintain large-scale facilities compliant with GMP and carry certifications such as ISO 9001 and ISO 22000. Their strategic geographic dispersion ensures global access and minimizes supply chain risks.


Suppliers of Potassium Chloride

Major Producers

  • AkzoNobel (Kemira Chemicals): Supplies high-purity pharmaceutical-grade potassium chloride, with extensive manufacturing capabilities across Europe and North America.

  • PotashCorp (Nutrien Ltd.): Produces potassium chloride primarily for agricultural use, but also supplies pharmaceutical-grade quality for IV applications through specialized divisions.

  • Des Toby's Chemical Company: A regional supplier providing GMP-certified potassium chloride suitable for IV solutions.

  • Lenzing Group: Focuses on high-purity formulations with rigorous regulatory compliance, optimizing safety in intravenous applications.

Industry Insights

Suppliers with capacity for ultra-pure, contamination-free potassium chloride are highly favored. Ongoing quality audits, validated manufacturing processes, and proven traceability are prerequisites.


Suppliers of Sodium Chloride

Key Players

  • Dow Chemical: Offers pharmaceutical-grade sodium chloride with a broad product portfolio, emphasizing purity, consistency, and compliance.

  • American Elements: Supplies high-grade sodium chloride suitable for medical and pharmaceutical applications, with extensive quality documentation.

  • OxyChem: A major producer supplying bulk pharmaceutical sodium chloride, emphasizing GMP adherence and purity.

  • Shandong Haihua Group: China's leading sodium chloride supplier, expanding globally with compliance standards aligned to EU and USP pharmacopoeia.

Strategic Importance

Given sodium chloride’s ubiquitous use, suppliers often operate at large scale, ensuring market stability. They maintain rigorous quality standards, including heavy metals testing and endotoxin control.


Suppliers of Sodium Lactate

Notable Providers

  • Cargill, Inc.: Supplies pharmaceutical-grade sodium lactate with high purity levels, supporting both formulations and aseptic processes.

  • Meihua Group: Chinese manufacturer with GMP-certified facilities specializing in electrolyte solutions, including sodium lactate with compliance to international standards.

  • Fresenius Kabi: Provides ready-to-use sodium lactate solutions, but also supplies raw materials for custom formulations.

  • Jiangsu Hengrui Medicine: Emerging supplier with GMP-certified bulk sodium lactate, expanding for international export.

Market Dynamics

Suppliers with proven purity, especially endotoxin-free, are preferred for intravenous use. The ability to scale manufacturing rapidly and comply with stringent regulatory standards remains key differentiators.


Strategic Sourcing Considerations

While regional diversification mitigates risks, reliance on suppliers with established GMP certifications and proven track records in pharmaceutical-grade manufacturing remains paramount. Supply chain resilience, especially for critical raw materials like calcium chloride and dextrose, demands strategic stockpiling, vendor validation, and continuous quality audits.

Emerging markets, notably China and India, are significant sources of these ingredients, driven by lower costs and increasing manufacturing capacity. However, global companies prioritize suppliers with comprehensive regulatory compliance and proven traceability to ensure patient safety and compliance with international standards.

Conclusion

The supply of calcium chloride, dextrose, potassium chloride, sodium chloride, and sodium lactate hinges on a network of globally distributed, highly regulated manufacturers. Leading suppliers like Cargill, Roquette, and Dow dominate their respective markets and offer dependable sources aligned with strict pharmacopoeial and GMP standards. Strategic sourcing from these suppliers ensures stability, safety, and compliance essential in pharmaceutical IV solution manufacturing.


Key Takeaways

  • Global Supplier Network: The majority of pharmaceutical-grade raw materials are sourced from large, GMP-compliant producers in North America, Europe, and Asia, emphasizing the importance of regional diversification for risk mitigation.

  • Regulatory Compliance: Suppliers with certifications such as USP, EP, JP, ISO 9001, and GMP are preferred for ensuring quality and facilitating regulatory approval.

  • Capacity and Scalability: The ability to scale production swiftly is crucial to meet surging demand, especially during global health crises.

  • Quality Assurance: Continuous quality monitoring, endotoxin testing, and traceability are essential for raw materials used in sterile, injectable solutions.

  • Emerging Markets: China and India are prominent sources, but rigorous supplier validation remains necessary to ensure compliance and supply chain integrity.


FAQs

1. How do manufacturers ensure the quality of raw materials like calcium chloride and dextrose?
Manufacturers select suppliers with GMP certifications, conduct raw material audits, and require Certificates of Analysis (CoA) ensuring compliance with pharmacopoeial standards (USP, EP, JP). Regular in-process testing and endotoxin assessments further assure quality.

2. What are the key factors influencing supplier selection for pharmaceutical raw materials?
Regulatory compliance, manufacturing capacity, product purity, quality assurance processes, lead times, and geographic location influence supplier choice. Establishing strong vendor relationships and conducting rigorous audits are also critical.

3. Are there regional risks associated with sourcing these raw materials?
Yes. Reliance on suppliers from regions prone to geopolitical instability, natural disasters, or supply chain disruptions can impact availability. Diversifying suppliers across regions mitigates such risks.

4. How does COVID-19 impact the supply of these raw materials?
The pandemic disrupted global supply chains, leading to shortages and delays. Many suppliers ramped up production and diversified sourcing to meet demand. Certifications and supply chain resilience have become more prominent in procurement strategies.

5. What future trends are shaping the raw material supplier landscape?
Enhanced focus on sustainability, stricter regulatory standards, innovation in green manufacturing practices, and increased localization are shaping supplier strategies. Additionally, digitalization and supply chain transparency are gaining importance for compliance and risk management.


References

[1] U.S. Pharmacopeia (USP); European Pharmacopoeia (EP); Japanese Pharmacopoeia (JP).
[2] International Organization for Standardization (ISO); GMP certification standards.
[3] Industry reports on pharmaceutical raw materials supply chain trends (e.g., IQVIA, Frost & Sullivan).
[4] Corporate disclosures from leading raw material manufacturers (Cargill, Roquette, Dow).


More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.